- Reuters•45 minutes ago
Bain Capital LP, Advent International Corp and Torrent Capital Investment Corp are on a shortlist of suitors for a Brazilian generic drug making joint-venture in which Pfizer Inc has a 40 percent stake, two people with direct knowledge of the situation said on Friday. According to the people, the three buyout firms presented more attractive terms than other drugmakers, including Israel's Teva Pharmaceutical Industries Ltd and Sun Pharmaceutical Industries Ltd, did for Teuto|Pfizer, as the venture is known. It controls Latin America's largest generic drugs plant.
- Zacks•1 hour ago
The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals
Given the current scenario of increased political, media and public pressure on drug pricing, it makes sense to zero in on companies that are in the biosimilars business.
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||32.37 x 5300|
|Ask||32.38 x 9800|
|Day's Range||32.23 - 32.42|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||28.65|
|Avg Vol (3m)||18,785,835|
|Dividend & Yield||1.20 (3.68%)|